Fadl-Elmula I: Chromosomal changes in uroepithelial carcinomas. Cell Chromosome. 2005, 4: 1-5. 10.1186/1475-9268-4-1.
Article
PubMed
PubMed Central
Google Scholar
Höglund M, Säll T, Heim S, Mitelman F, Mandahl N, Fadl-Elmula I: Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma. Cancer Res. 2001, 61: 8241-8246.
PubMed
Google Scholar
Richter J, Jiang F, Gorog JP, Sartorius G, Egenter C, Gasser TC, Moch H, Mihatsch MJ, Sauter G: Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res. 1997, 57: 2860-2864.
CAS
PubMed
Google Scholar
Richter J, Beffa L, Wagner U, Schraml P, Gasser TC, Moch H, Mihatsch MJ, Sauter G: Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol. 1998, 153: 1615-1621.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhao J, Richter J, Wagner U, Roth B, Schraml P, Zellweger T, Ackermann D, Schmid U, Moch H, Mihatsch MJ, Gasser TC, Sauter G: Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res. 1999, 59: 4658-4661.
CAS
PubMed
Google Scholar
Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM: Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res. 2003, 63: 2872-2880.
CAS
PubMed
Google Scholar
Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, Koppie T, Pejavar S, Mehta K, Carroll P, Simko JP, Waldman FM: Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res. 2005, 11: 7012-7022. 10.1158/1078-0432.CCR-05-0177.
Article
CAS
PubMed
Google Scholar
Hurst CD, Fiegler H, Carr P, Williams S, Carter NP, Knowles MA: High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene. 2004, 23: 2250-2263. 10.1038/sj.onc.1207260.
Article
CAS
PubMed
Google Scholar
Jönsson G, Bendahl PO, Sandberg T, Kurbasic A, Staaf J, Sunde L, Cruge DG, Ingvar C, Olsson H, Borg Å: Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32. J Natl Cancer Inst. 2005, 97: 1377-1382.
Article
PubMed
Google Scholar
The Swegene DNA Micro Array Resource Center. [http://swegene.onk.lu.se]
Krzywinski M, Bosdet I, Smailus D, Chiu R, Mathewson C, Wye N, Barber S, Brown-John M, Chan S, Chand S, Cloutier A, Girn N, Lee D, Masson A, Mayo M, Olson T, Pandoh P, Prabhu AL, Schoenmakers E, Tsai M, Albertson D, Lam W, Choy CO, Osoegawa K, Zhao S, de Jong PJ, Schein J, Jones S, Marra MA: A set of BAC clones spanning the human genome. Nucleic Acids Res. 2004, 32: 3651-3660. 10.1093/nar/gkh700.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heidenblad M, Hallor KH, Staaf J, Jönsson G, Borg Å, Höglund M, Mertens F, Mandahl N: Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays. Oncogene. 2006, 25: 7106-16. 10.1038/sj.onc.1209693.
Article
CAS
PubMed
Google Scholar
Saal LH, Troein C, Vallon-Christersson J, Gruvberger S, Borg Å, Peterson C: BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol. 2003, 3: SOFTWARE0003.
Google Scholar
Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP: Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002, 30: e15-10.1093/nar/30.4.e15.
Article
PubMed
PubMed Central
Google Scholar
Autio R, Hautaniemi S, Kauraniemi P, Yli-Harja O, Astola J, Wolf M, Kallioniemi A: CGH-Plotter: MATLAB toolbox for CGH-data analysis. Bioinformatics. 2005, 19: 1714-1715. 10.1093/bioinformatics/btg230.
Article
Google Scholar
The UCSC genome browser, May 2004 freeze. [http://genome.ucsc.edu]
Tusher VG, Tibshirani R, Chu G: Significance analysis of micro arrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001, 98: 5116-5121. 10.1073/pnas.091062498.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heidenblad M, Jonson T, Mahlamäki EH, Gorunova L, Karhu R, Johansson B, Höglund M: Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification. Genes Chromosomes Cancer. 2002, 34: 211-223. 10.1002/gcc.10063.
Article
CAS
PubMed
Google Scholar
Jin Y, Stewenius Y, Lindgren D, Frigyesi A, Calcagnile O, Jonson T, Edqvist A, Larsson N, Lundberg LM, Chebil G, Liedberg F, Gudjonsson S, Månsson W, Höglund M, Gisselsson D: Distinct mitotic segregation errors mediate chromosomal instability in aggressive urothelial cancers. Clin Cancer Res. 2007, 13: 1703-1712. 10.1158/1078-0432.CCR-06-2705.
Article
CAS
PubMed
Google Scholar
Richter J, Wagner U, Schraml P, Maurer R, Alund G, Knonagel H, Moch H, Mihatsch MJ, Gasser TC, Sauter G: Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res. 1999, 59: 5687-5691.
CAS
PubMed
Google Scholar
Bruch J, Schulz WA, Haussler J, Melzner I, Bruderlein S, Moller P, Kemmerling R, Vogel W, Hameister H: Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines. Cancer Res. 2000, 60: 4526-4530.
CAS
PubMed
Google Scholar
Oeggerli M, Tomovska S, Schraml P, Calvano-Forte D, Schafroth S, Simon R, Gasser T, Mihatsch MJ, Sauter G: E2F3 amplification and over expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene. 2004, 23: 5616-5623. 10.1038/sj.onc.1207749.
Article
CAS
PubMed
Google Scholar
Feber A, Clark J, Goodwin G, Dodson AR, Smith PH, Fletcher A, Edwards S, Flohr P, Falconer A, Roe T, Kovacs G, Dennis N, Fisher C, Wooster R, Huddart R, Foster CS, Cooper CS: Amplification and overexpression of E2F3 in human bladder cancer. Oncogene. 2004, 23: 1627-1630. 10.1038/sj.onc.1207274.
Article
CAS
PubMed
Google Scholar
Wu Q, Hoffmann MJ, Hartmann FH, Schulz WA: Amplification and over expression of the ID4 gene at 6p22.3 in bladder cancer. Molecular Cancer. 2005, 4 (16): 1-10.
Google Scholar
Evans AJ, Gallie BL, Jewett MAS, Pond GR, Vandezande K, Underwood J, Fradet Y, Lim G, Marrano P, Zielenska M, Squire JA: defining a 0.5-Mb region of genomic gain on chrosmsome 6p22 in bladder cancer by quantitative-multplex polymerase chain reaction. Am J Pathol. 2004, 164: 285-293.
Article
CAS
PubMed
PubMed Central
Google Scholar
Oeggerli M, Schraml P, Ruitz C, Bloch M, Novotny H, Mirlacher M, Sauter G, Simon R: E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer. Oncogene. 2006, 25: 6538-6543. 10.1038/sj.onc.1209946.
Article
CAS
PubMed
Google Scholar
Olsson AY, Feber A, Edwards S, te Poele R, Giddings I, Merson S, Cooper CS: Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene. 2007, 26: 1028-37. 10.1038/sj.onc.1209854.
Article
CAS
PubMed
Google Scholar
Trimarchi JM, Lees JA: Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol. 2002, 3: 11-20. 10.1038/nrm714.
Article
CAS
PubMed
Google Scholar
Ginsberg D: E2F3-a novel repressor of the ARF/p53 pathway. Dev Cell. 2004, 6: 742-743. 10.1016/j.devcel.2004.05.012.
Article
CAS
PubMed
Google Scholar
Dong C, Wilhelm D, Koopman P: Sox genes and cancer. Cytogenet Genome Res. 2004, 105: 442-447. 10.1159/000078217.
Article
CAS
PubMed
Google Scholar
Aaboe M, Birkenkamp-Demtroder K, Wiuf C, Sorensen FB, Thykjaer T, Sauter G, Jensen KM, Dyrskjot L, Orntoft T: SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Res. 2005, 66: 3434-3442. 10.1158/0008-5472.CAN-05-3456.
Article
Google Scholar
Pramoonjago P, Baras AS, Moskaluk CA: Knockdown of Sox4 expression by RNAi induces apoptosis in ACC3 cells. Oncogene. 2006, 25: 5626-39. 10.1038/sj.onc.1209566.
Article
CAS
PubMed
Google Scholar
Wise-Draper TM, Allen HV, Thobe MN, Jones EE, Habash KB, Munger K, Wells SI: The human DEK proto-oncogene is a senescence inhibitor and an up regulated target of high-risk human papillomavirus E7. J Virol. 2005, 79: 14309-14317. 10.1128/JVI.79.22.14309-14317.2005.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carro MS, Spiga FM, Quarto M, Di Ninni V, Volorio S, Alcalay M, Muller H: DEK expression is controlled by E2F and deregulated in diverse tumor types. Cell Cycle. 2006, 5: 1202-1207.
Article
CAS
PubMed
Google Scholar
Ball JR, Ullman KS: Versatility at the nuclear pore complex: lessons learned from the nucleoporin Nup 153. Chromosoma. 2005, 114: 319-330. 10.1007/s00412-005-0019-3.
Article
PubMed
Google Scholar
Porter GW, Khuri FR, Fu H: Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. Semin Cancer Biol. 2006, 16: 193-202. 10.1016/j.semcancer.2006.03.003.
Article
CAS
PubMed
Google Scholar
Jang JS, Cho HY, Lee YJ, Ha WS, Kim HW: The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res. 2004, 14: 491-499.
CAS
PubMed
Google Scholar
Zang L, Palmer D, Hancock WS, Sgroi DC, Karger BL: Proteomic analysis of ductal carcinoma of the breast using laser capture micro dissection, LC-MS, and 16O/18O isotopic labeling. Proteome Res. 2004, 3: 604-612. 10.1021/pr034131l.
Article
CAS
Google Scholar
Arora S, Matta A, Shukla NK, Deo SV, Ralhan R: Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog. 2005, 42: 97-108. 10.1002/mc.20048.
Article
CAS
PubMed
Google Scholar
Qi W, Liu X, Qiao D, Martinez JD: Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer. 2005, 113: 359-363. 10.1002/ijc.20492.
Article
CAS
PubMed
Google Scholar
Tzivion G, Gupta VS, Kaplun L, Balan V: 14-3-3 proteins as potential oncogenes. Semin Cancer Biol. 2006, 16: 203-213. 10.1016/j.semcancer.2006.03.004.
Article
CAS
PubMed
Google Scholar
Cox C, Bignell G, Greenman C, Stabenau A, Warren W, Stephens P, Davies H, Watt S, Teague J, Edkins S, Birney E, Easton DF, Wooster R, Futreal PA, Statton MR: A survey of homozygous deleletions in human cancer genomes. Proc Natl Acad Sci USA. 2005, 102: 4542-4547. 10.1073/pnas.0408593102.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chapman EJ, Harnden P, Chambers P, Johnston C, Knowles M: A comprehensive analysis of CDKN2A status in micro dissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype. Clin Cancer Res. 2005, 11: 5740-5747. 10.1158/1078-0432.CCR-05-0411.
Article
CAS
PubMed
Google Scholar
Williams SV, Sibley KD, Davies AM, Nishiyama H, Hornigold N, Coulter J, Kennedy WJ, Skilleter A, Habuchi T, Knowles MA: Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines. Genes Chromosomes Cancer. 2002, 34: 86-96. 10.1002/gcc.10050.
Article
CAS
PubMed
Google Scholar
van Tilborg AA, de Vries A, de Bont M, Groenfeld LE, Zwarthoff EC: The random development of LOH on chromosome 9q in superficial bladder cancers. J Pathol. 2002, 198: 352-358. 10.1002/path.1215.
Article
CAS
PubMed
Google Scholar